Showing 1,241 - 1,260 results of 39,683 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 5 ((non decrease) OR (nn decrease)) ))', query time: 1.22s Refine Results
  1. 1241
  2. 1242
  3. 1243
  4. 1244

    MTT assay shows that the cells exposed to periostin siRNA showed a significant decrease in IC50 among the DDP, EPI, and DTX compared with the control siRNA group (control group) (<i>P</i><0.01). by Dongyang Xu (303547)

    Published 2013
    “…<p>MTT assay shows that the cells exposed to periostin siRNA showed a significant decrease in IC50 among the DDP, EPI, and DTX compared with the control siRNA group (control group) (<i>P</i><0.01).…”
  5. 1245
  6. 1246

    A non-RBD epitope neutralizes the cell entry of SARS-CoV-2 Omicron variant. by Gang Ye (318792)

    Published 2024
    “…<p><b>(A)</b> Pseudovirus entry assay shows that Nanosota-5-Fc neutralizes the cell entry of three Omicron subvariants. …”
  7. 1247

    siRNA mediated knockdown of hZNF-134 decreased the viral transcript levels and the final viral titer output measured by p24 ELISA. by Ronald Benjamin (440573)

    Published 2014
    “…Scrambled siRNA was used as a control. 50picomoles of each siRNA were used. …”
  8. 1248
  9. 1249
  10. 1250

    Cumulative effects and geographic distribution of mCHG-decreasing alleles. by Eriko Sasaki (501178)

    Published 2022
    “…The insert shows the six observed genotypes with three mCHG-decreasing and the <i>NRPE1’</i> non-reference allele. …”
  11. 1251
  12. 1252
  13. 1253

    A Functional 12T-Insertion Polymorphism in the <i>ATP1A1</i> Promoter Confers Decreased Susceptibility to Hypertension in a Male Sardinian Population by Victoria L. Herrera (383897)

    Published 2015
    “…The <i>ATP1A1</i> promoter containing the 12T-insertion exhibited decreased transcriptional activity in in vitro reporter-assay systems, indicating decreased α1Na,K-ATPase expression with the 12T-insertion, compared with the 12T-deletion <i>ATP1A1</i> promoter. …”
  14. 1254
  15. 1255
  16. 1256
  17. 1257

    The prevalence of hypertension, diabetes, metabolic syndrome, cardiovascular disease and decreased GFR according to the following age groups: 60–69, 70–79 and ≥80 years. by Regina C. R. M. Abdulkader (302450)

    Published 2017
    “…Metabolic syndrome: presence of at least three of the following criteria: a waist circumference ≥90 cm for men or ≥80 cm for women, triglycerides ≥150 mg/dL, an HDL cholesterol ≤40 mg/dL for males or ≤50 mg/dL for females, a systolic blood pressure ≥130 mm Hg or a diastolic blood pressure ≥85 mmHg and a fasting plasma glucose ≥100 mg/dL. …”
  18. 1258
  19. 1259
  20. 1260